Skip to main content
Figure 1 | Journal of Experimental & Clinical Cancer Research

Figure 1

From: HSP70: a promising target for laryngeal carcinoma radiaotherapy by inhibiting cleavage and degradation of nucleolin

Figure 1

HSP70 expression in LSCC tissues. High HSP70 expression in late stage of LSCC tissues (a-b) was showed comparing to the low HSP70 expression in early stage LSCC(c), (d) is the negative control show the specificity of the antibody. HSP70 shows strong expression (scored as 3+, a), moderate expression (scored as 2+, b), weak expression (scored as 1+, c), and negative expression (scored as 0, d) in cytoplasm(×400).

Back to article page